182 related articles for article (PubMed ID: 14592421)
1. Pub, a novel PU.1 binding protein, regulates the transcriptional activity of PU.1.
Hirose S; Nishizumi H; Sakano H
Biochem Biophys Res Commun; 2003 Nov; 311(2):351-60. PubMed ID: 14592421
[TBL] [Abstract][Full Text] [Related]
2. Pip, a lymphoid-restricted IRF, contains a regulatory domain that is important for autoinhibition and ternary complex formation with the Ets factor PU.1.
Brass AL; Kehrli E; Eisenbeis CF; Storb U; Singh H
Genes Dev; 1996 Sep; 10(18):2335-47. PubMed ID: 8824592
[TBL] [Abstract][Full Text] [Related]
3. SPI-C, a PU-box binding ETS protein expressed temporarily during B-cell development and in macrophages, contains an acidic transactivation domain located to the N-terminus.
Carlsson R; Persson C; Leanderson T
Mol Immunol; 2003 Jun; 39(16):1035-43. PubMed ID: 12749910
[TBL] [Abstract][Full Text] [Related]
4. PU.1 binding to ets motifs within the equine infectious anemia virus long terminal repeat (LTR) enhancer: regulation of LTR activity and virus replication in macrophages.
Hines R; Sorensen BR; Shea MA; Maury W
J Virol; 2004 Apr; 78(7):3407-18. PubMed ID: 15016863
[TBL] [Abstract][Full Text] [Related]
5. Identification of a monopartite sequence in PU.1 essential for nuclear import, DNA-binding and transcription of myeloid-specific genes.
Kwok JC; Perdomo J; Chong BH
J Cell Biochem; 2007 Aug; 101(6):1456-74. PubMed ID: 17340619
[TBL] [Abstract][Full Text] [Related]
6. Mutation analysis of the Pip interaction domain reveals critical residues for protein-protein interactions.
Ortiz MA; Light J; Maki RA; Assa-Munt N
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2740-5. PubMed ID: 10077581
[TBL] [Abstract][Full Text] [Related]
7. Negative cross-talk between hematopoietic regulators: GATA proteins repress PU.1.
Zhang P; Behre G; Pan J; Iwama A; Wara-Aswapati N; Radomska HS; Auron PE; Tenen DG; Sun Z
Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8705-10. PubMed ID: 10411939
[TBL] [Abstract][Full Text] [Related]
8. Assembly requirements of PU.1-Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimers.
Brass AL; Zhu AQ; Singh H
EMBO J; 1999 Feb; 18(4):977-91. PubMed ID: 10022840
[TBL] [Abstract][Full Text] [Related]
9. SPI-B activates transcription via a unique proline, serine, and threonine domain and exhibits DNA binding affinity differences from PU.1.
Rao S; Matsumura A; Yoon J; Simon MC
J Biol Chem; 1999 Apr; 274(16):11115-24. PubMed ID: 10196196
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of PU.1/IRF-4/DNA ternary complex.
Escalante CR; Brass AL; Pongubala JM; Shatova E; Shen L; Singh H; Aggarwal AK
Mol Cell; 2002 Nov; 10(5):1097-105. PubMed ID: 12453417
[TBL] [Abstract][Full Text] [Related]
11. The sequence-specific association of the ETS domain of murine PU.1 with DNA exhibits unusual energetics.
Poon GM; Gross P; Macgregor RB
Biochemistry; 2002 Feb; 41(7):2361-71. PubMed ID: 11841229
[TBL] [Abstract][Full Text] [Related]
12. Prf, a novel Ets family protein that binds to the PU.1 binding motif, is specifically expressed in restricted stages of B cell development.
Hashimoto S; Nishizumi H; Hayashi R; Tsuboi A; Nagawa F; Takemori T; Sakano H
Int Immunol; 1999 Sep; 11(9):1423-9. PubMed ID: 10464163
[TBL] [Abstract][Full Text] [Related]
13. The Ets protein Spi-B is expressed exclusively in B cells and T cells during development.
Su GH; Ip HS; Cobb BS; Lu MM; Chen HM; Simon MC
J Exp Med; 1996 Jul; 184(1):203-14. PubMed ID: 8691135
[TBL] [Abstract][Full Text] [Related]
14. The hematopoietic cell-specific transcription factor PU.1 is critical for expression of CD11c.
Yashiro T; Kasakura K; Oda Y; Kitamura N; Inoue A; Nakamura S; Yokoyama H; Fukuyama K; Hara M; Ogawa H; Okumura K; Nishiyama M; Nishiyama C
Int Immunol; 2017 Feb; 29(2):87-94. PubMed ID: 28338898
[TBL] [Abstract][Full Text] [Related]
15. FLI1 and EWS-FLI1 function as ternary complex factors and ELK1 and SAP1a function as ternary and quaternary complex factors on the Egr1 promoter serum response elements.
Watson DK; Robinson L; Hodge DR; Kola I; Papas TS; Seth A
Oncogene; 1997 Jan; 14(2):213-21. PubMed ID: 9010223
[TBL] [Abstract][Full Text] [Related]
16. Genetic and physical interactions between Microphthalmia transcription factor and PU.1 are necessary for osteoclast gene expression and differentiation.
Luchin A; Suchting S; Merson T; Rosol TJ; Hume DA; Cassady AI; Ostrowski MC
J Biol Chem; 2001 Sep; 276(39):36703-10. PubMed ID: 11481336
[TBL] [Abstract][Full Text] [Related]
17. Analysis of PU.1/ICSBP (IRF-8) complex formation with various PU.1 mutants: molecular cloning of rat Icsbp (Irf-8) cDNA.
Nakano N; Nishiyama C; Masuoka N; Nishiyama M; Yamane H; Okumura K; Ogawa H
Immunogenetics; 2005 Mar; 56(12):871-7. PubMed ID: 15688197
[TBL] [Abstract][Full Text] [Related]
18. Physical and functional interactions between the transcription factor PU.1 and the coactivator CBP.
Yamamoto H; Kihara-Negishi F; Yamada T; Hashimoto Y; Oikawa T
Oncogene; 1999 Feb; 18(7):1495-501. PubMed ID: 10050886
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of a PU.1/Spi-B binding site in the bovine leukemia virus long terminal repeat.
Dekoninck A; Calomme C; Nizet S; de Launoit Y; Burny A; Ghysdael J; Van Lint C
Oncogene; 2003 May; 22(19):2882-96. PubMed ID: 12771939
[TBL] [Abstract][Full Text] [Related]
20. In vivo complex formation of PU.1 with HDAC1 associated with PU.1-mediated transcriptional repression.
Kihara-Negishi F; Yamamoto H; Suzuki M; Yamada T; Sakurai T; Tamura T; Oikawa T
Oncogene; 2001 Sep; 20(42):6039-47. PubMed ID: 11593411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
